• Welcome - F. Vaghaiwalla Mody
• Debate I: Ischemic Heart Disease - PCI vs CABG    
  • Case Presentation - V. Blumer
  • PCI - R. Mehran
  • CABG - A. Ardehali
• Debate II: Mitral Valve Disease - Mitral Clip TEER vs Surgical MVR    
  • Case Presentation - V. Blumer
  • Mitral Clip - M. Calfon Press
  • Surgical MVR - V. Chan
• Debate III: Aortic Stenosis - TAVR vs Surgical AVR    
  • Case Presentation - V. Blumer
  • TAVR - R. Makkar
  • Surgical AVR - M. Mack
• Closing Remarks - F. Vaghaiwalla Mody

• Review the current data on the options for coronary revascularization, when, how, and who benefits for it
• To review the current indications and risk regarding valvular intervention in heart fail-ure, and the data that support surgical vs. percutaneous valvular intervention

• To identify clinical criteria in heart failure patients that benefit from advanced thera-pies and refer in a timely fashion
• To gain knowledge of the indications and contraindications associated with percuta-neous and surgical coronary and valvular interventions
• To gain knowledge of potential complications associated with interventional and sur-gical interventions.

• Freny Vaghaiwalla Mody, MD – VA Greater Los Angeles Healthcare System
• Fellow/Early Career Moderator: Vanessa Blumer, MD – Cleveland Clinic

• Abbas Ardehali, MD – University of California, Los Angeles
• Marcella Calfon Press MD, PhD – University of California, Los Angeles
• Vincent Chan, MD, MPH – University of Ottawa Heart Institute
• Michael Mack, MD – Baylor Scott & White Health
• Raj Makkar, MD – Cedars-Sinai
• Roxana Mehran, MD – Mount Sinai Hospital

The Heart Failure Society of America (HFSA) is committed to ensuring balance, independence, objectivity, and scientific rigor in its educational activities. HFSA has a disclosure policy that requires oral presenters to disclose all relevant financial relationships for themselves and their spouse or partner during the past 24 months with any commercial entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on patients and related to the content of the activity, whether or not these commercial entities are supporters of the activity.

Speakers will have a disclosure slide at the beginning of each presentation. All potential conflicts of interests have been resolved in accordance with the ACCME Updated Standards for Commercial Support.

The following faculty and/or accreditors with ability to control content for this activity have no conflict of interest:

• Abbas Ardehali, MD
• Nelly Aghili, DNP, APRN, AGACNP-BC
• Vanessa Blumer, MD
• Vincent Chan, MD
• Jennifer Cook, MD
• Marcella Calfon Press MD, PhD

• Michael Mack, MD – Trial Co-PI: Abbott, Edwards Lifesciences; Study Chair: Medtronic Raj Makkar, MD – Research Grant: Abbott, Edwards Lifesciences, Boston Scientific; Consultant: Cordis, Medtronic
• Roxana Mehran, MD – Institutional Research Payment: Abbott, Abiomed, Alleviant Medical, Amgen, AM-Pharma, Arena, AstraZeneca, Atricure, Bayer, Biosensors, Biotronik, Boston Scientific, Bristol-Myers Squibb, CardiaWave, CeloNova, Chiesi, Concept Medical, CSL Behring, Cytosorbents, Daiichi Sankyo, Element Science, Faraday, Filter-lex Medical, Humacyte, Idorsia Pharmaceuticals, Janssen, Mediasphere, Medtel-ligence, Medtronic, Novartis, OrbusNeich, Penumbra, PhaseBio, Philips, Pi-Cardia, PLx Pharma, Protembis, RenalPro, RM Global, Shockwave, Vi-vasure, Zoll; Consultant: Cine-Med Research, Ionis Phar-maceuticals, Novartis, Novo Nordisk, Vectura, WebMD; Other: Scientific Advisory Board for AMA, ACC (BOT Member, SC Member CTR Program), SCAI (Women in Innovations Commit-tee Member), JAMA Cardiology Associate Editor; Faculty CRF (no fee).
• Freny Vaghaiwalla Mody, MD – Research: National Institutes of Health, Merck, LivaNova, Novartis

Off-Label Disclosure
This CME activity may or may not discuss investigational, unapproved, or off-label use of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options for a specific patient’s medical condition.